Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV001380994 | SCV005442789 | pathogenic | Phenylketonuria | 2024-09-06 | reviewed by expert panel | curation | The c.1237C>A (p.Arg413Ser) variant in PAH has been reported in 1 patient with mild hyperphenylalenemia (BH4 deficiency excluded). This variant has been reported in at least 2 in vitro studies showing <50% PAH activity as compared to wild type. This variant is absent from population databases, and is predicted deleterious by SIFT, PolyPhen2, MutationTaster, REVEL = 0.934. This variant is at the same codon as c.1238G>C (p.Arg413Pro) which has been curated as pathogenic by the ClinGen PAH VCEP (ClinVarID:592). In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PS3_supporting, PM2_supporting, PM5, PP4_Moderate, PP3_strong. |
Labcorp Genetics |
RCV001380994 | SCV001579239 | pathogenic | Phenylketonuria | 2020-03-14 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with serine at codon 413 of the PAH protein (p.Arg413Ser). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and serine. This variant is not present in population databases (ExAC no frequency). This variant has been observed in combination with another PAH variant in an individual affected with hyperphenylaninemia (PMID: 10479481). ClinVar contains an entry for this variant (Variation ID: 102575). This variant has been reported to affect PAH protein function (PMID: 10479481). This variant disrupts the p.Arg413 amino acid residue in PAH. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 24401910, 27264808, 17935162, 21953985, 30459323). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV001380994 | SCV005053829 | likely pathogenic | Phenylketonuria | 2024-02-08 | criteria provided, single submitter | clinical testing | |
De |
RCV000088811 | SCV000119401 | not provided | not provided | no assertion provided | not provided |